Log in

NYSE:ACBAurora Cannabis Stock Price, Forecast & News

$14.23
-0.07 (-0.49 %)
(As of 06/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$13.92
Now: $14.23
$14.45
50-Day Range
$0.67
MA: $10.49
$17.40
52-Week Range
$5.30
Now: $14.23
$97.92
Volume4.60 million shs
Average Volume6.66 million shs
Market Capitalization$1.45 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.79
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.9Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.52 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone1-855-279-4652

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$215.10 million
Book Value$39.12 per share

Profitability

Net Income$-219,670,000.00
Net Margins-442.62%

Miscellaneous

Employees2,779
Market Cap$1.45 billion
Next Earnings Date9/9/2020 (Estimated)
OptionableOptionable

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

How has Aurora Cannabis' stock been impacted by COVID-19 (Coronavirus)?

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACB shares have increased by 38.1% and is now trading at $14.23. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Aurora Cannabis?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 5 sell ratings, 9 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Aurora Cannabis.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for Aurora Cannabis.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc (NYSE:ACB) released its earnings results on Thursday, November, 14th. The company reported $0.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.36) by $0.48. The company had revenue of $57.02 million for the quarter, compared to analysts' expectations of $72.82 million. Aurora Cannabis had a negative net margin of 442.62% and a negative return on equity of 8.55%. View Aurora Cannabis' earnings history.

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Aurora Cannabis's stock reverse split before market open on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for ACB?

17 analysts have issued 12-month price objectives for Aurora Cannabis' shares. Their forecasts range from $10.00 to $108.00. On average, they anticipate Aurora Cannabis' share price to reach $27.93 in the next year. This suggests a possible upside of 96.3% from the stock's current price. View analysts' price targets for Aurora Cannabis.

Has Aurora Cannabis been receiving favorable news coverage?

News headlines about ACB stock have been trending very negative on Friday, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Aurora Cannabis earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutAurora Cannabis.

Are investors shorting Aurora Cannabis?

Aurora Cannabis saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 217,440,000 shares, an increase of 13.1% from the April 15th total of 192,210,000 shares. Based on an average trading volume of 31,400,000 shares, the short-interest ratio is currently 6.9 days. Approximately 16.7% of the company's stock are sold short. View Aurora Cannabis' Current Options Chain.

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), HEXO (HEXO), NVIDIA (NVDA), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), Micron Technology (MU) and General Electric (GE).

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 54)
  • Mr. Terry Booth, Founder, CEO & Director (Age 54)
  • Mr. Stephen Dobler, Founder, Pres & Director (Age 54)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a variety of retail and institutional investors. Top institutional investors include ETF Managers Group LLC (26.85%), Swiss National Bank (0.35%), Public Sector Pension Investment Board (3.45%), Morgan Stanley (3.29%), Morgan Stanley (3.29%) and JPMorgan Chase & Co. (0.24%).

Which major investors are selling Aurora Cannabis stock?

ACB stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, Janus Henderson Group PLC, CIBC World Markets Inc., Cambridge Investment Research Advisors Inc., CIBC Asset Management Inc, AdvisorShares Investments LLC, Sigma Planning Corp, and Raymond James Financial Services Advisors Inc..

Which major investors are buying Aurora Cannabis stock?

ACB stock was bought by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Swiss National Bank, Voloridge Investment Management LLC, SG Americas Securities LLC, Public Sector Pension Investment Board, Geode Capital Management LLC, Bank of New York Mellon Corp, and Morgan Stanley.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $14.23.

How big of a company is Aurora Cannabis?

Aurora Cannabis has a market capitalization of $1.45 billion and generates $215.10 million in revenue each year. The company earns $-219,670,000.00 in net income (profit) each year or ($2.64) on an earnings per share basis. Aurora Cannabis employs 2,779 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.